428 related articles for article (PubMed ID: 31702638)
1. Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review.
Chen WX; Li GX; Hu ZN; Zhu P; Zhang BX; Ding ZY
Medicine (Baltimore); 2019 Nov; 98(45):e17832. PubMed ID: 31702638
[TBL] [Abstract][Full Text] [Related]
2. Significant response to pembrolizumab plus lenvatinib in Epstein-Barr-virus-associated intrahepatic cholangiocarcinoma: a case report.
Li L; Yu D; Yang J; Zhang F; Zhang D; Lin Z; Zhai M; Wang J; Zhang T; Zhao L
Cancer Biol Ther; 2024 Dec; 25(1):2338644. PubMed ID: 38650446
[TBL] [Abstract][Full Text] [Related]
3. Complete response of recurrent perihilar cholangiocarcinoma following sintilimab combined with lenvatinib plus S-1: a case report and review of literature.
Liu QQ; Yu XH; Tang QB; Chen D; Zhang R; Liu C; Shi XD
Anticancer Drugs; 2024 Jan; 35(1):81-85. PubMed ID: 37227031
[TBL] [Abstract][Full Text] [Related]
4. Lenvatinib Plus Programmed Cell Death Protein-1 Inhibitor Beyond First-Line Systemic Therapy in Refractory Advanced Biliary Tract Cancer: A Real-World Retrospective Study in China.
Shi C; Li Y; Yang C; Qiao L; Tang L; Zheng Y; Chen X; Qian Y; Yang J; Wu D; Xie F
Front Immunol; 2022; 13():946861. PubMed ID: 35967452
[TBL] [Abstract][Full Text] [Related]
5. Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma With a High Tumor Mutational Burden and PD-L1 Expression by PD-1 Blockade Combined With Tyrosine Kinase Inhibitors: A Case Report.
Zhang Z; Zhang W; Wang H; Hu B; Wang Z; Lu S
Front Immunol; 2021; 12():744571. PubMed ID: 34603331
[TBL] [Abstract][Full Text] [Related]
6. [A Case of TMB-High Recurrent Peritoneal Seeding in Hilar Cholangiocarcinoma Treated with Pembrolizumab Therapy].
Shinke G; Takeda Y; Ohmura Y; Kinoshita M; Katsura Y; Aoyama S; Kihara Y; Yanagisawa K; Katsuyama S; Ikeshima R; Hiraki M; Sugimura K; Masuzawa T; Hata T; Murata K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1875-1877. PubMed ID: 38303237
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma.
Huang Y; Du Z; Kan A; He M; Li H; Lai Z; Wen D; Huang L; Li Q; Xu L; Shi M
Front Immunol; 2024; 15():1260191. PubMed ID: 38384459
[TBL] [Abstract][Full Text] [Related]
8. Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review.
Zhang W; Luo C; Zhang ZY; Zhang BX; Chen XP
Front Immunol; 2022; 13():1079342. PubMed ID: 36700218
[TBL] [Abstract][Full Text] [Related]
9. Clinical response to adding pyrotinib to pembrolizumab and lenvatinib for HER2-positive advanced intrahepatic cholangiocarcinoma: a case report.
Zhang JW; Yang X; Pan B; Xu Y; Lu X; Zhao HT
World J Surg Oncol; 2023 Mar; 21(1):108. PubMed ID: 36973682
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Long-Term Survival with Multidisciplinary Treatment for Postoperative Local Recurrence of Intrahepatic Cholangiocarcinoma].
Sakai K; Gotoh K; Toshiyama R; Tokuyama S; Kawai K; Takahashi Y; Hamakawa T; Doi T; Takeno A; Kato T; Takami K; Hirao M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1795-1797. PubMed ID: 38303210
[TBL] [Abstract][Full Text] [Related]
11. Durable response with lenvatinib and pembrolizumab combination therapy in a patient with pre-treated metastatic cholangiocarcinoma.
Dreikhausen L; Kusnik A; Schulte N; Eckardt M; Teufel A; Gaiser T; Ebert M; Zhan T
J Gastrointestin Liver Dis; 2021 Sep; 30(3):409-410. PubMed ID: 34551034
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma.
Zhao R; Zhou J; Miao Z; Xiong X; Wei W; Li S; Guo R
Front Immunol; 2024; 15():1397827. PubMed ID: 38799453
[TBL] [Abstract][Full Text] [Related]
13. [A long term survival case of hilar cholangiocarcinoma with multiple metastases treated with chemotherapy and operation].
Shirasaki K; Morikawa T; Otsuka H; Katayose Y; Unno M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1530-2. PubMed ID: 25731242
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic Cholangiocarcinoma with High Microsatellite Instability and Tumor Mutation Burden That Responded Significantly to Pembrolizumab but Perforated within a Short Period.
Yamazaki S; Kubota K; Shimizu A; Notake T; Umemura K; Kamachi A; Goto T; Tomida H; Yamashita N; Sato M; Kanno H; Soejima Y
Intern Med; 2024 Apr; 63(8):1105-1112. PubMed ID: 37779076
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Multidisciplinary Treatment Including Lenvatinib].
Furuya K; Ioka T; Shindo Y; Tokumitsu Y; Matsui H; Matsukuma S; Nakajima M; Yamada K; Watanabe Y; Tomochika S; Yoshida S; Iida M; Suzuki N; Takeda S; Nagano H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1694-1696. PubMed ID: 35046300
[TBL] [Abstract][Full Text] [Related]
16. [A Case of an Advanced Intrahepatic Cholangiocarcinoma Effectively Treated by Conversion Surgery after Neoadjuvant Chemotherapy of Gemcitabine, Cisplatin and S-1].
Ogura N; Hoshino M; Hayashi T; Odaira M; Harada H; Hirose S; Funakoshi S
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1665-1667. PubMed ID: 36733169
[TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial infusion chemotherapy plus lenvatinib with or without programmed cell death protein-1 inhibitors for advanced cholangiocarcinoma.
Wei Z; Wang Y; Wu B; Liu Y; Wang Y; Ren Z; Yang X; Chen Q; Zhang Y
Front Immunol; 2023; 14():1235724. PubMed ID: 37720223
[TBL] [Abstract][Full Text] [Related]
18. [A case of curatively resected advanced intrahepatic cholangiocellular carcinoma through effective response to neoadjuvant chemotherapy].
Hashimoto K; Tono T; Nishida K; Nonaka R; Tsunashima R; Fujie Y; Fujita S; Fujita J; Yoshida T; Ohnishi T; Imaoka S; Monden T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2083-5. PubMed ID: 25731430
[TBL] [Abstract][Full Text] [Related]
19. [A case of curative resection after downsizing chemotherapy in initially unresectable locally advanced intrahepatic cholangiocarcinoma].
Aoki Y; Suzuki T; Kato A; Shimizu H; Ohtsuka M; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Okamura D; Suzuki D; Sakai N; Kagawa S; Miyazaki M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1509-11. PubMed ID: 25731235
[TBL] [Abstract][Full Text] [Related]
20. Effects of the anti-epidermal growth factor receptor antibody cetuximab on cholangiocarcinoma of the liver.
Huang TW; Wang CH; Hsieh CB
Onkologie; 2007 Mar; 30(3):129-31. PubMed ID: 17341899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
